• SENSEX 82,530.74
    1,200.18 (+1.48%)
  • BANKNIFTY 55,355.60
    554.30 (+1.01%)
  • Cochin Shipyard
    1,831.00 2,977.10(%)
  • One 97
    863.90 1,063.00(%)
  • Mazagon Dock
    3,217.65 3,229.00(%)
  • Garden Reach Sh.
    2,340.00 2,834.60(%)
  • Tata Motors
    729.95 1,179.05(%)
  • Hind.Aeronautics
    4,883.00 5,675.00(%)
  • OneSource Speci.
    1,567.95 1,163.05(%)
  • Bharat Electron
    351.00 351.00(%)
  • Suzlon Energy
    61.77 86.04(%)
  • St Bk of India
    809.50 912.10(%)
  • Yes Bank
    21.70 27.41(%)
  • Reliance Industr
    1,461.00 1,608.95(%)
  • Vodafone Idea
    7.27 19.15(%)
  • Bharti Airtel
    1,869.65 1,916.90(%)
  • Tata Power Co.
    404.55 494.85(%)
  • Swiggy
    318.00 617.00(%)
  • Infosys
    1,618.85 2,006.80(%)
  • Dixon Technolog.
    16,520.00 19,149.80(%)
  • Jio Financial
    274.40 376.00(%)
  • ITC
    435.40 500.01(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Mangalam Drugs and Organics Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 20249.0
  • ISIN : INE584F01014
80.38 0 (0.34%)
  • As on 16 May 2025 (EOD)

  • Today’s Low

    80.00

  • Today’s High

    81.49

  • Open

    81.49

  • Perv Close

    80.11

  • 52W Low

    70.10

  • 52W High

    144.99

Key Indicators

  • P/E(TTM)

    12.31

  • Mar.Cap (₹Cr.)

    127.23

  • Div & Yield %

    0.00

  • Book Value(₹)

    93.15

  • Debt-Equity Ratio

    0.34

  • AGM Date

    15-May-2025

  • EPS

    6.52

  • P/E Ratio

    12.31

Financials Ratios

  • Debt-Equity Ratio

    0.78

  • Mar.Cap (₹Cr.)

    127.23

  • RONW (%)

    -6.68

  • ROCE (%)

    1.16

Score Board

  • Equity (₹ in Cr.)

    15.83

  • BV (₹)

    93.10

  • Sales( ₹ in Cr.)

    368.59

  • NP (in Cr.)

    -9.00

  • NP Var(%)

    -808.0

  • Div%

    0.0

  • CPS (₹)

    3.60

  • EPS (₹)

    -5.70

  • Traded Value (₹ in Lakhs)

    127.05

  • 52 Week High

    144.99

  • 52 Week Low

    70.10

  • Price BSE

    80.0

  • Price NSE

    80.00

  • Market Capital( in Cr.)

    127.05

  • P/C Ratio

    22.50

  • P/E Ratio

    -14.10

  • Price Vs.BV

    -5.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 368.59 372.25 451.07 379.98 313.13 258.81
Excise Duty 0.00 0.00 0.00 0.00 30.78 31.23
Net Sales 368.59 372.25 451.07 379.98 282.35 227.58
Other Income 0.10 0.44 0.09 4.72 1.18 0.32
Stock Adjustments -9.10 42.16 33.75 4.23 -17.28 15.39
Total Income 359.59 414.85 484.91 388.93 266.25 243.29
EXPENDITURE :            
Raw Materials 235.41 292.60 340.39 256.19 178.07 168.70
Power and Fuel Cost 28.50 25.59 22.90 16.12 14.24 14.56
Employee Cost 39.07 34.61 37.25 29.88 26.04 25.82
Other Manufacturing Expenses 13.26 11.58 11.92 8.11 7.37 6.86
Selling and Administration Expenses 13.10 11.60 13.64 16.19 14.24 17.02
Miscellaneous Expenses 12.76 12.71 9.67 4.42 1.42 0.32
Employee Benefit Expenses 39.07 34.61 37.25 29.88 26.04 25.82
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 342.10 388.69 435.77 330.91 241.38 233.29
Operating Profit 17.49 26.16 49.14 58.02 24.87 10.00
Interest 13.92 12.96 11.16 9.33 10.40 8.65
Gross Profit 3.57 13.20 37.98 48.69 14.47 1.35
Depreciation 14.63 10.99 10.25 9.18 8.22 7.09
Profit Before Tax -11.06 2.21 27.73 39.51 6.25 -5.74
Current Tax 0.19 -0.03 8.81 9.27 0.05 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -2.20 0.97 -0.73 2.28 -2.05 2.29
Reported Net Profit -9.05 1.27 19.66 27.97 8.25 -8.03
Extraordinary Items -0.05 0.00 0.06 0.00 -0.04 -0.03
Adjusted Net Profit -9.00 1.27 19.60 27.97 8.29 -8.00
Adjustment below Net Profit -0.56 0.12 0.12 -1.12 0.02 -0.08
P & L Balance brought forward 102.96 101.57 81.79 54.94 46.67 54.77
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down 93.35 102.96 101.57 81.79 54.94 46.67
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -5.72 0.80 12.42 17.67 5.21 0.00
Earnings Per Share(Adj)-Unit Curr -5.72 0.80 12.42 17.67 5.21 0.00
Book Value 89.93 96.00 95.12 82.63 65.67 60.44
Book Value(Adj)-Unit Curr 89.93 96.00 95.12 82.63 65.67 60.44

Shareholding Pattern

  • Promoter Group

    50.30%

  • Public Share Holding

    49.70%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,951,698 31.28 4,951,698 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,010,348 19.02 3,010,348 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,962,046 50.30 7,962,046 18
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 306 0.00 306 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 73,609 0.47 73,609 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 73,915 0.47 73,915 4
2] Non Institution
Bodies Corporate 300,766 1.90 300,766 67
Clearing Members 2,475 0.02 2,475 3
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 183,814 1.16 183,814 330
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 231,390 1.46 231,390 292
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,163,438 13.67 2,163,438 44
Individuals holding nominal share capital up to Rs. 1 lakh 4,888,001 30.88 4,887,991 18,933
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,792,287 49.23 7,792,277 19,675
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 15,828,248 100.00 15,828,238 19,697

Company Background

Mangalam Drugs and Organics LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Mangalam Drugs and Organics Ltd
  • BSE Code : 20249.0
  • ISIN : INE584F01014

  • Incorporation Year

    1972

  • Registered Office

    3rd Floor Rupam Building
    239 P D Mello Road, Mumbai,
    Maharashtra-400001

  • Telephone

    91-22-22616200/6300/8787

  • FAX

    91-22-26190900

  • Chairman

    Govardhan M Dhoot

  • Managing Director

    Govardhan M Dhoot

  • Company Secretary

    Anuradha Pandey

  • Auditor

    V S Somani & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Mangalam Drugs and Organics Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Mangalam Drugs 80.27 368.69 368.59 12.31 1.16
Abbott India 30,371.20 6,097.18 5,848.91 48.36 44.71
Astrazeneca Phar 7,947.60 1,330.33 1,295.53 204.89 33.26
P & G Health Ltd 5,247.85 1,166.89 1,151.26 36.82 39.76
Glaxosmi. Pharma 2,878.70 3,530.73 3,407.25 53.06 44.44
Cipla 1,502.25 17,645.00 16,574.34 23.52 20.10
Amrutanjan Healt 717.35 437.58 421.23 42.05 20.84
Guj. Themis Bio. 325.45 174.19 169.82 67.38 44.82
Fermenta Biotec. 288.75 315.24 307.09 27.37 4.10
Bliss GVS Pharma 120.45 638.96 605.46 18.39 11.19
Ambalal Sarabhai 38.18 11.70 3.81 16.32 1.92